Ann-Kathrin Ozga
Ann-Kathrin Ozga
M. Sc.
  • Scientist
Working area



W34, Ground Floor, Room number 9b
German (Mother tongue)

Areas of expertise

Curriculum vitae




Reevaluation of risk factors for time to subsequent events after first stroke occurrence using a new weighted all-cause effect measure
Ozga A, Rauch B, Palm F, Urbanek C, Grau A, Becher H, Rauch G
BMC PUBLIC HEALTH. 2020;20(1):817.

Treatment and re-treatment results of HCV patients in the DAA era
Piecha F, Gänßler J, Ozga A, Wehmeyer M, Dietz J, Kluwe J, Laschtowitz A, von Felden J, Sterneck M, Jordan S, Pischke S, Lohse A, Schulze Zur Wiesch J
PLOS ONE. 2020;15(5):e0232773.

Tibial plateau fracture: does fracture classification influence the choice of surgical approach? A retrospective multicenter analysis
Rossmann M, Fensky F, Ozga A, Rueger J, Märdian S, Russow G, Brunnemer U, Schmidmaier G, Hofmann A, Herlyn P, Mittlmeier T, Amer A, Gösling T, Grossterlinden L
EUR J TRAUMA EMERG S. 2020 [Epub ahead of print].


Introducing a new estimator and test for the weighted all-cause hazard ratio
Ozga A, Rauch G
BMC MED RES METHODOL. 2019;19(1):118.

Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival
Piecha F, Radunski U, Ozga A, Steins D, Drolz A, Horvatits T, Spink C, Ittrich H, Benten D, Lohse A, Sinning C, Kluwe J
JHEP Reports. 2019;1(2):90-98.

Relapse rates and long-term outcome in primary angiitis of the central nervous system
Schuster S, Ozga A, Stellmann J, Deb-Chatterji M, Häußler V, Matschke J, Gerloff C, Thomalla G, Magnus T
J NEUROL. 2019;266(6):1481-1489.

Risikofaktoren für einen gemischten Chimerismus nach Stammzelltransplantation mit Treosulfan- oder Melphalanbasierter Konditionierung bei Kindern und Jugendlichen mit primärer Hämophagozytischer Lymphohistiozytose
Wustrau K, Albert M, Bader P, Beier R, Burkhardt B, Chada M, Greil J, Gruhn B, Kühl J, Lang P, Meisel R, Schulz A, Seidel M, Speckmann C, Sykora K, Wawer A, Wößmann W, Ozga A, Janka-Schaub G, Ehl S, Müller I, Lehmberg K
2019. Monatsschrift Kinderheilkunde > Ausgabe 7/2018 . 646-647.


Oral health-related quality of life and standard of treatment in aggressive periodontitis patients more than 5 years after therapy
Bäumer A, Kappesz D, Ozga A, Mertens C, Eickholz P, Pretzl B
J CLIN PERIODONTOL. 2018;45(11):1347-1355.

Response for letter "Be cautious in comparing the seroprevalence of hepatitis E detected at different years in different countries"
Horvatits T, Ozga A, Lohse A, Dalton H, Pischke S
LIVER INT. 2018;38(12):2341.

Hepatitis E seroprevalence in the Americas: A systematic review and meta-analysis
Horvatits T, Ozga A, Westhölter D, Hartl J, Manthey C, Lütgehetmann M, Rauch G, Kriston L, Lohse A, Bendall R, Wedemeyer H, Dalton H, Pischke S
LIVER INT. 2018;38(11):1951-1964.

A systematic comparison of recurrent event models for application to composite endpoints
Ozga A, Kieser M, Rauch G
BMC MED RES METHODOL. 2018;18(1):2.

Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome
Piecha F, Mandorfer M, Peccerella T, Ozga A, Poth T, Vonbank A, Seitz H, Rausch V, Reiberger T, Mueller S
AM J PHYSIOL-GASTR L. 2018;315(4):G484-G494.

Revival of transcatheter PFO closure: A meta-analysis of randomized controlled trials - impact of shunt size and age
Reinthaler M, Ozga A, Sinning D, Curio J, Al-Hindwan H, Bäckemo Johansson J, Jung F, Lendlein A, Rauch G, Landmesser U
AM HEART J. 2018;201:95-102.

Risk factors for mixed chimerism after stem cell transplantation with treosulfan or melphalan based conditioning regimens in children and adolescents with primary hemophagocytic lymphohistocytosis
Wustrau K, Albert M, Bader P, Beier R, Burkhardt B, Chada M, Greil J, Gruhn B, Kühl J, Lang P, Meisel R, Schulz A, Seidel M, Speckmann C, Sykora K, Wawer A, Wößmann W, Ozga A, Ehl S, Müller I, Lehmberg K
2018. Bone Marrow Transplantation (2018) Abstracts Collection. .


Lateral cephalometric analysis for treatment planning in orthodontics based on MRI compared with radiographs: A feasibility study in children and adolescents
Heil A, Lazo Gonzalez E, Hilgenfeld T, Kickingereder P, Bendszus M, Heiland S, Ozga A, Sommer A, Lux C, Zingler S
PLOS ONE. 2017;12(3):e0174524.


Simulating recurrent event data with hazard functions defined on a total time scale
Jahn-Eimermacher A, Ingel K, Ozga A, Preussler S, Binder H

Letzte Aktualisierung aus dem FIS: 14.07.2020 - 06:28 Uhr